First Time Loading...
V

VIVA Biotech Holdings
HKEX:1873

Watchlist Manager
VIVA Biotech Holdings
HKEX:1873
Watchlist
Price: 0.61 HKD 15.09%
Updated: May 3, 2024

VIVA Biotech Holdings
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

VIVA Biotech Holdings
Net Income (Common) Peer Comparison

Comparables:
603259
300759
2269
300347
W
2268

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
V
VIVA Biotech Holdings
HKEX:1873
Net Income (Common)
-¥116.1m
CAGR 3-Years
33%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Net Income (Common)
¥9.6B
CAGR 3-Years
48%
CAGR 5-Years
34%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Net Income (Common)
¥1.6B
CAGR 3-Years
11%
CAGR 5-Years
37%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Net Income (Common)
¥3.4B
CAGR 3-Years
26%
CAGR 5-Years
40%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Net Income (Common)
¥2B
CAGR 3-Years
5%
CAGR 5-Years
34%
CAGR 10-Years
36%
W
WuXi XDC Cayman Inc
HKEX:2268
Net Income (Common)
¥155.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is VIVA Biotech Holdings's Net Income (Common)?
Net Income (Common)
-116.1m CNY

Based on the financial report for Dec 31, 2023, VIVA Biotech Holdings's Net Income (Common) amounts to -116.1m CNY.

What is VIVA Biotech Holdings's Net Income (Common) growth rate?
Net Income (Common) CAGR 3Y
33%

Over the last year, the Net Income (Common) growth was 78%. The average annual Net Income (Common) growth rates for VIVA Biotech Holdings have been 33% over the past three years .